Influence of <i>k</i>₁ on the homeostatic behavior of the m7 ping-pong controller when <i>E</i>₁ binds first to free enzyme <i>Ez</i>. by Qaiser Waheed (5095328)

“…(c) A decrease of <i>k</i>₆ from 5.0 to 1.0 while <i>k</i>₁ is kept at 100.0 gives a general improvement of the homeostatic performance of the ping-pong controller, except for the higher end <i>k</i>₅ range between 900–1000, where <i>A</i>_<i>ss</i> becomes constant (indicated by the red circle). …”

Dataset for: Leptin attenuates D2 receptor-mediated inhibition of putative ventral tegmental area dopaminergic neurons by Takami Murakami (4842903)

“…We suggest that leptin directly decreases, and indirectly increases, excitability of VTA dopaminergic neurons. …”

Surround Modulation Characteristics of Local Field Potential and Spiking Activity in Primary Visual Cortex of Cat by Li Zhang (8200)

“…When the stimulus went beyond the classical receptive field, LFP exhibited decreased power along the gamma band (30–100 Hz) in most of our recording sites. …”

Sensory axons, but not soma, from Type III Nrg1^+/− mice show reduced capsaicin responsiveness compared to axons from WT mice. by Sarah E. Canetta (46254)

“…Averages of 5 animals per genotype were compared using a Student's t-test. Type III Nrg1^+/− axons showed a significantly decreased response to capsaicin (p<0.05), but not to KCl, relative to WTs. …”

Typical trajectory of an individual honeybee in the doubly-tapered tunnel. by Geoffrey Portelli (221361)

“…(B) Side view of the actual trajectory of a honeybee, plotted every 100 ms. The honeybee's course was fairly well centered in the tunnel (mean height <i>h</i> = 19±0.19 cm). …”

Table_1_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_2_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Image_1_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.JPEG... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_4_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_3_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_5_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior-3 by Yu Fu (16582)

“…Bar histograms show averaged EPSC amplitudes (mean ± SE) normalized to predrug control values (set to 100%). …”

Febuxostat suppresses LPS-induced MCP-1 production via MKP-1-dependent inhibition of JNK through increasing MKP-1 activity. by Johji Nomura (462919)

“…<p>Cells incubated for 30 min with vanadate (200 µM) or Ro-31-8220 (1 µM) were pretreated for 10 min with febuxostat (30 µM) or NAC (10 mM), and then stimulated for 1 (A) or 2 h (B) with 100 ng/mL LPS. (A) Western blot analysis using anti-phospho-JNK and β-actin antibodies. …”

Methylation of <i>PLA2G16</i> increases in tumor and normal prostate tissue from patients with PC. by William E. Jarrard (6871892)

“…The values in both A and B are from 3 individual experiments, shown as Mean ± SEM, one way Anova, *p<0.05. …”

The pathway of photoreceptor cell death does not include PDE6β. by Takeshi Nakao (173997)

“…Rod photoreceptors are visualized with EGFP (Green). (Bar = 100 µm.) In <i>ovl</i>, the number of rod photoreceptors was decreased. …”

Quantitative Analysis of the Extracellular Response Kinase 1 and 2 (ERK1/2), Calcium-Calmodulin Kinase II (CAMKII), Fragile X Protein (FMRP), and the Nicotinic Acetylcholine Recept... by Robert K. Naviaux (256148)

“…<p>(A) ERK1 (MAPK3) and ERK2 (MAPK1) phosphorylation was decreased by over 90% by gestational poly(IC) exposure and normalized by suramin treatment (Sal-Sal = 100+/−5%; Sal-Sur = 6.2+/−0.8%; PIC-Sal = 9.9+/−2.6%; PIC-Sur = 84+/−2.3%; one-way ANOVA F(3,12) = 241; p<0.0001; n = 4–5 males per group; age = 16 weeks). …”

PBM does not affect the rate of neurogenesis in aged 3xTg mice. by Kevin J. Johnson (2647639)

“…<p><b>A.</b> Representative images of DCX (red) and calretinin (CR, green) stained dentate gyrus sections showing DCX+ cells (arrowheads) and CR+ cells in the subgranular zone and granule cell layer (Scale bars = 100µm) <b>B.…”

Histology of pancreas following cell therapy. by Reza B. Jalili (845889)

“…<p>Histology of representative pancreas sections of NOD mice before (at the commencement of autoimmune diabetes) and after cell therapy is shown. Panel <b>A</b> shows hematoxylin-eosin staining (left and center) and insulin immuno-staining (right) of pancreas sections of a NOD mouse euthanized in the first week after the onset of hyperglycemia. …”

Phenotypic characterization of pCAME-treated embryos. by Evelien Gebruers (495875)

“…<p>(A) Embryo treated with 100 μg/mL crude methanolic extract of <i>J. gilgianum</i>. …”

Predicted impact of interventions on the number of local infections in the Ehlanzeni district (summation of the five local patches). by Sheetal Prakash Silal (477585)

“…<p>(a) shows the impact of the interventions on local infections in Ehlanzeni district through time compared to the base case of no interventions (black) and (b) shows the percentage change (increase or decrease) in point estimates of local infections due to the interventions between 2013 and 2018. (1) Local Scale-up: Increase in local vector control so as to reduce the mosquito-human contact rate by a further 10% (red), three consecutive two-monthly rounds of MDA in Mbombela, Nkomazi and Bushbuckridge Municipalities (green). (2) FSAT at the border: at 70% coverage for 26 weeks (red), 39 weeks (green), 52 weeks (blue) and 52 weeks at 100% coverage (purple). (3) Reducing Vector Control: FSAT at the border at 70% coverage administered all year round while simultaneously reducing vector control by 10% (red), 20% (green) and stopping vector control altogether (blue). (4) Source Reduction: 10% scale up of vector control in Maputo (red), three consecutive two-monthly rounds of MDA in Maputo (green) and eliminating malaria in Maputo (blue). …”